Regulation of cellular response to oncogenic and oxidative stress by Seladin-1

Nature

Volumn 432, Issue 7017, 2004, Pages 640-645

  Wu, Chaowei ^a   Miloslavskaya, Irene ^a   Demontis, Silvia ^b   Maestro, Roberta ^b   Galaktionov, Konstantin ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DISEASE CONTROL; GENES; METABOLISM; MUTAGENS; ONCOLOGY; TUMORS;

MAMMALIAN CELLS; SENESCENCE; TUMOUR SUPPRESSORS;

CELLS;

PROTEIN; PROTEIN MDM2; PROTEIN P16; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SELADIN 1; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

TUMOR;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CANCER; CANCER CELL; CARCINOGENESIS; CHOLESTEROL METABOLISM; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE EXPRESSION; GENETIC SCREENING; HUMAN; HUMAN CELL; MAMMAL CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE RAS; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RAT; SENESCENCE;

AMINO ACID SEQUENCE; ANIMALS; CELL AGING; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; FIBROBLASTS; HUMANS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; ONCOGENE PROTEIN P21(RAS); OXIDATIVE STRESS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RATS; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; MAMMALIA; RODENTIA;

EID: 10344229445     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03173     Document Type: Article

References (27)

1. Ruley, H. E. Adenovirus early region IA enables viral and cellular transforming genes to transform primary cells in culture. Nature 304, 602-606 (1983).
2. Land, H., Parada, L. F. & Weinberg, R. A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304, 596-602 (1983).
3. Hahn, W. C. et al. Creation of human tumour cells with defined genetic elements. Nature 400, 464-468 (1999).
4. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602 (1997).
5. Lee, A. C. et al. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J. Biol. Chem. 274, 7936-7940 (1999).
6. Greeve, I. et al. The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J. Neurosci. 20, 7345-7352 (2000).
7. Waterham, H. R. et al. Mutations in the 3β-hydroxysterol Δ24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am. J. Hum. Genet. 69, 685-694 (2001).
8. Gudkov, A. V. et al. Cloning mammalian genes by expression selection of genetic suppressor elements: association of kinesin with drug resistance and cell immortalization. Proc. Natl Acad. Sci. USA 91, 3744-3748 (1994).
9. Takahashi, T., Gasch, A., Nishizawa, H. & Chua, N. H. The DIMINUTO gene of Arabidopsis is involved in regulating cell elongation. Genes Dev. 9, 97-107 (1995).
10. Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 92, 9363-9367 (1995).
11. Hahn, W. C. & Weinberg, R. A. Modelling the molecular circuitry of cancer. Nature Rev. Cancer 2, 331-341 (2002).
12. Brummelkamp, T. R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553 (2002).
13. Lin, A. W. & Lowe, S. W. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation. Proc. Natl Acad. Sci. USA 98, 5025-5030 (2001).
14. Brookes, S. et al. INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence. EMBO J. 21, 2936-2945 (2002).
15. Dimri, G. P., Itahana, K., Acosta, M. & Campisi, J. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor. Mol. Cell Biol. 20, 273-285 (2000).
16. 2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication. Biochem. J. 332, 43-50 (1998).
17. Cadet, J., Berger, M., Douki, T. & Ravanat, J. L. Oxidative damage to DNA: formation, measurement, and biological significance. Rev. Physiol Biochem. Pharmacol. 131, 1-87 (1997).
18. Hoeijmakers, J. H. Genome maintenance mechanisms for preventing cancer. Nature 411, 366-374 (2001).
19. Wei, W., Hemmer, R. M. & Sedivy, J. M. Role of p14(ARF) in replicative and induced senescence of human fibroblasts. Mol. Cell. Biol. 21, 6748-6757 (2001).
20. Xiao, Z. et al. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375, 694-698 (1995).
21. Sun, P., Dong, P., Dai, K., Hannon, G. J. & Beach, D. p53-independent role of MDM2 in TGF-β1 resistance. Science 282, 2270-2272 (1998).
22. Martin, K. et al. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375, 691-694 (1995).
23. Hsieh, J. et al. RB regulates the stability and the apoptotic function of p53 via MDM2. Mol. Cell 3, 181-193 (1999).
24. Ganguli, G. & Wasylyk, B. p53-independent functions of MDM2. Mol. Cancer Res. 1, 1027-1035 (2003).
25. Xirodimas, D., Saville, M. K., Bourdon, J. C., Hay, R. T. & Lane, D. P. Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell 118, 83-97 (2004).
26. Cutler, R. G. et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl Acad. Sci. USA 101, 2070-2075 (2004).
27. Thompson, J. D., Higgins, D. G. & Gibson, T. J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673-4680 (1994).